Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
European Journal of Medicinal Chemistry|December 15, 2021
Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activityZhanhui Li, Yongjin Hao, Chengkui Yang, et al.British Journal of Pharmacology|June 30, 2021
Honokiol inhibits proliferation of colorectal cancer cells by targeting anoctamin 1/TMEM16A Ca2+ -activated Cl- channelsTianyu Wang, Hui Wang, Fan Yang, et al.Bioorganic Chemistry|September 17, 2022
Discovery, optimization and evaluation of isothiazolo[5,4-b]pyridine derivatives as RIPK1 inhibitors with potent in vivo anti-SIRS activityYongjin Hao, Chengkui Yang, Chang Shu, et al.Bioorganic Chemistry|April 26, 2020
Design, synthesis, and evaluation of novel CXCR4 antagonists based on an aminoquinoline templateYu Lin, Zhanhui Li, Chen Xu, et al.European Journal of Medicinal Chemistry|August 10, 2020
Design, synthesis, and evaluation of pyrrolidine based CXCR4 antagonists with in vivo anti-tumor metastatic activityZhanhui Li, Xu Wang, Yu Lin, et al.Biochemical Pharmacology|June 14, 2023
Discovery of a novel RIPK2 inhibitor for the treatment of inflammatory bowel diseaseYujun Lai, Xinhui Wang, Xue Sun, et al.Journal of Advanced Research|October 4, 2021
Activation of TMEM16A Ca2+-activated Cl- channels by ROCK1/moesin promotes breast cancer metastasisShuya Luo, Hui Wang, Lichuan Bai, et al.Journal of Advanced Research|February 20, 2020
TMEM16A Ca2+-activated Cl- channel inhibition ameliorates acute pancreatitis via the IP3R/Ca2+/NFκB/IL-6 signaling pathwayQinghua Wang, Lichuan Bai, Shuya Luo, et al.Cell Death & Disease|December 22, 2025
USP7 promotes chemotherapy resistance and DNA damage response through stabilizing and deubiquitinating KDM4A in bladder cancerHailang Yang, Xiaoqiang Liu, Jianqiang Nie, et al.Chemmedchem|May 12, 2020
Design, Synthesis, and Characterization of Novel CXCR4 Antagonists Featuring Cyclic AminesYu Lin, Zhanhui Li, Haikuo Ma, et al.Pageof 4